BOSTON, April 11, 2019 /PRNewswire/ — Intrinsic Therapeutics, Inc., a medical device company focusing on surgeries to treat leg and low back pain resulting from ruptured lumbar discs with large anular defects, today announced a $52m Series Growth equity financing.  Questa Capital led the round, with participation from existing investors New Enterprise Associates (NEA), Greenspring Associates, Quadrille, and Delos …